What AI says about Nova In Silico
Nova In Silico provides a collaborative clinical trial simulation platform called jinkō that predicts clinical outcomes before human trials.
Since Jul 5Updated Nov 14, 2026Based on 1,220 AI answers
Reviewed by Dimitry Apollonsky
Mentioned in · Public index
<1%
of AI answers about Nova In Silico and its rivals · since Jul 5
Based on 1,220 AI answers
- ChatGPT0%
- Google AI Mode1%
How often AI mentions Nova In Silico
of AI answers about Nova In Silico and its rivals
Track your brand free to see 13 weeks of history.
Use the left and right arrow keys to read each date.
Sep 14OctNov 2
- · ChatGPT switched to GPT-6 Luna
Questions and answers
- Most mentionedMentioned in
- Which platform uses AI synthetic control arms to shrink trial control groups?on this questionMedidata is the most-mentioned brand10%
Excerpts where Nova In Silico appeared in the AI's answer
Google AI ModeAug 21, 2026, Google AI Mode Nova In Silico Synthetic control arms can do more than reduce the time, costs, and practical and ethical hurdles of clinical trials.
Google AI ModeJul 28, 2026, Google AI Mode Nova In Silico (JINKŌ®) : A platform that enables drug developers to simulate virtual populations and control arms
Nova In Silico in AI answers
Which platform uses AI synthetic control arms to shrink trial control groups?
ChatGPTChatGPTNo answer mentioning Nova In Silico
Google AI ModeGoogle AI Mode· Aug 21, 2026
Nova In Silico Synthetic control arms can do more than reduce the time, costs, and practical and ethical hurdles of clinical trials.
Sites AI cites
- Your site100%
The page AI cites most often when it mentions Nova In Silico
Brands AI mentions
Mentioned in
- Medidata29%
- Qureight1%
- Ariana Pharma1%
- Quibim<1%
- VEIL.AI<1%
